News and research

What is actuallyhappening, withsources attached.

Court cases, state policy, and research findings, in India and elsewhere. Same rule as the rest of the site: every claim names its source, and we correct ourselves in public when a detail turns out to be wrong.

12 May 2026WorldWhere cannabis policy actually stands, country by country, in 2026Germany runs partial legalisation with no open commercial market. Thailand reversed course and reclassified cannabis flower as a controlled herb in mid-2025. The US remains a 24-state patchwork under a Schedule I federal law that just partially bent. No two countries are doing the same thing.Read →24 April 2026WorldThe US just moved some cannabis to Schedule III. Here is exactly what changed, and what did notOn 23 April 2026 the DOJ immediately rescheduled state-licensed medical cannabis, but recreational cannabis stays Schedule I everywhere. A separate DEA hearing on broader rescheduling opens 29 June 2026.Read →6 February 2026PolicyA Delhi High Court bench declined to decriminalise ganja, and ordered a review insteadThe court said decriminalisation is a policy question, not a judicial one, and told the Union government to consult stakeholders on whether the NDPS Act needs dilution. Reported deadlines vary by source.Read →31 January 2026PolicyHimachal Pradesh is growing licensed hemp. Here is what the pilot actually allowsThe state cabinet approved a controlled cultivation pilot in January 2025, run through two agricultural universities, with a hard 0.3% THC ceiling. It is a hemp programme, not a step toward recreational cannabis.Read →15 December 2025ResearchA review of 2,500 studies looked at medical cannabis. Here is the honest version of what it foundTrial evidence supports cannabinoids for a short, specific list of conditions, chemotherapy nausea and MS spasticity among them, and does not support most of what is popularly claimed. That gap is the actual story.Read →3 November 2025ResearchA 460,000-person study on teenage cannabis use, read carefullyPast-year cannabis use among 13 to 17 year olds was associated with significantly elevated risk of psychotic, bipolar, depressive and anxiety disorders by age 26. Association is not the same as proof of cause, and the study does not claim it is.Read →